Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,541,040
  • Shares Outstanding, K 34,174
  • Annual Sales, $ 441,540 K
  • Annual Income, $ 35,460 K
  • EBIT $ 96 M
  • EBITDA $ 116 M
  • 60-Month Beta 2.06
  • Price/Sales 9.18
  • Price/Cash Flow 82.35
  • Price/Book 13.04

Options Overview Details

View History
  • Implied Volatility 84.26% (-1.20%)
  • Historical Volatility 41.60%
  • IV Percentile 74%
  • IV Rank 49.93%
  • IV High 124.49% on 02/27/25
  • IV Low 44.14% on 06/10/25
  • Expected Move (DTE 28) 21.68 (16.15%)
  • Put/Call Vol Ratio 0.66
  • Today's Volume 1,599
  • Volume Avg (30-Day) 810
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 21,724
  • Open Int (30-Day) 19,123
  • Expected Range 112.58 to 155.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.41
  • Number of Estimates 7
  • High Estimate 0.55
  • Low Estimate 0.28
  • Prior Year 0.19
  • Growth Rate Est. (year over year) +115.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.00 +5.71%
on 02/05/26
145.74 -7.88%
on 01/28/26
-7.68 (-5.41%)
since 01/20/26
3-Month
119.29 +12.54%
on 12/16/25
156.00 -13.94%
on 12/02/25
+10.43 (+8.42%)
since 11/20/25
52-Week
62.07 +116.28%
on 03/06/25
156.00 -13.94%
on 12/02/25
+58.80 (+77.93%)
since 02/20/25

Most Recent Stories

More News
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANDOVER, Mass. , Feb. 20, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics to Present at Upcoming March Investor Conferences

ANDOVER, Mass. , Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ANDOVER, Mass. , Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

ANDOVER, Mass. , Feb. 9, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

ANDOVER, Mass. , Jan. 12, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing...

TMDX : 134.25 (+1.03%)
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

ANDOVER, Mass. , Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANDOVER, Mass. , Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

ANDOVER, Mass. , Nov. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANDOVER, Mass. , Oct. 31, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

TMDX : 134.25 (+1.03%)
TransMedics: Q3 Earnings Snapshot

TransMedics: Q3 Earnings Snapshot

TMDX : 134.25 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation....

See More

Key Turning Points

3rd Resistance Point 141.73
2nd Resistance Point 138.62
1st Resistance Point 136.43
Last Price 134.25
1st Support Level 131.13
2nd Support Level 128.02
3rd Support Level 125.83

See More

52-Week High 156.00
Last Price 134.25
Fibonacci 61.8% 120.12
Fibonacci 50% 109.04
Fibonacci 38.2% 97.95
52-Week Low 62.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar